GW29-e1034 Can eastern Asian population with acute coronary syndrome derive short-term cardiac benefit from high dose statin loading prior to percutaneous coronary intervention ?: systematic review and meta-analysis

[...]most relevant studies obtained a preponderance of western population, therefore the presumptive magnitude of cardiac benefit merits scrutiny in Asian population.Our aim is to synthesise data from major randomized controlled trials to gain insight into this controversy.Methods Literature in Medl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-10, Vol.72 (16), p.C108-C109
Hauptverfasser: Huang, Taiyuan, Zhou, Qi, Yang, Yuan, Luo, Suxin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page C109
container_issue 16
container_start_page C108
container_title Journal of the American College of Cardiology
container_volume 72
creator Huang, Taiyuan
Zhou, Qi
Yang, Yuan
Luo, Suxin
description [...]most relevant studies obtained a preponderance of western population, therefore the presumptive magnitude of cardiac benefit merits scrutiny in Asian population.Our aim is to synthesise data from major randomized controlled trials to gain insight into this controversy.Methods Literature in Medline and Embase database from inception to 31 March 2018 were scrutinized for relevant studies using Internet-based search engines. 1919 patients were identified from 9 randomized studies for the present meta-analysis.The primary endpoint was the 30-day incidence of major adverse cardiac events (MACEs) inclusive of death,myocardial infarction (MI), stroke, target vessel revascularization (TVR).Results High dose statin loading was associated with a significant lower 30-day rate of MACEs compared with conventional care (6.96% vs. 12.3%; odds ratio [OR]: 0.47; 95% confidence interval [CI]: 0.30 to 0.74; p = 0.001), driven by reduction in the occurrence of MI (5% vs. 8.73%; OR: 0.50; 95% CI: 0.34 to 0.73; p = 0.0004) whereas no significant differences in death (0.2% vs. 0.9%; OR: 0.37; 95% CI: 0.09 to 1.44; p = 0.15), stroke (0.5% vs. 0.8%; OR: 0.63; 95% CI: 0.20 to 1.98; p =0.43) or TVR (0.7% vs. 1.6%; OR: 0.54; 95% CI: 0.23 to 1.27; p =0.16). To assess whether specific category of statin was more likely related to the optimal results, a subgroup analysis was performed for studies where rosuvastatin or atorvastatin was prescribed in high dose statin loading, and a prominent benefit was observed in the rosuvastatin subgroup (OR: 0.37; 95% CI: 0.24 to 0.58; p = 0.0001) with absence of heterogeneity (I2 = 0%; p = 0.74), whereas pretreatment with high dose of atorvastatin did not significantly attenuate MACEs rate within 30 days post PCI. Based on the visual inspection of the funnel plot and Egger's test for MACEs, the presence of a small publication bias was suggested.Conclusions From the available RCT data pertaining to high dose statin loading prior to PCI in eastern Asian patients with ACS, a consistent tendency was revealed in favor of MACEs and the component endpoints of death or MI occurrence 30 days post PCI as in some large clinical trials conducted in western population.
doi_str_mv 10.1016/j.jacc.2018.08.539
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2117125248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109718363563</els_id><sourcerecordid>2117125248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1248-2f308be080854e8ea340345b208e0314632f591369ef58f9a73121547f808e7b3</originalsourceid><addsrcrecordid>eNp9Uc2q1DAULqLgePUFXB1w3ZqfZpqKIJdBr8IFN4rLkElP76RMk5qkc5kn9XU84wjuXIXA93u-qnrNWcMZ376dmsk61wjGdcN0o2T_pNpwpXQtVd89rTask6rmrO-eVy9ynhhjW837TfXr7ofoa-RMtrCzAdDmginAbfb0W-KyHm3xMcCjLwewbi0ILqYYbDpDPochxRlhwORPCPkQU6mJP4OzafDWwR4Djr7ASDg4-IcDDDETspBqgGO0gw8PsCQfE5QICyaysAHjmv_5-ECaJwx_gnx4R74UciYFBwlPHh_BhgFmLLa2wR7P2eeX1bPRHjO--vveVN8_ffy2-1zff737sru9rx0Xra7FKJneI9NMqxY1WtnSJdReMI1M8nYrxah6Lrc9jkqPve0kF1y13UgM7Pbypnpz1V1S_LliLmaKa6IQ2QjOOy4U2RBKXFEuxZwTjoYaz1TNcGYuA5rJXAY0lwEN04YGJNL7KwkpP7VMJjuPweHgE7pihuj_R_8NuOmnrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2117125248</pqid></control><display><type>article</type><title>GW29-e1034 Can eastern Asian population with acute coronary syndrome derive short-term cardiac benefit from high dose statin loading prior to percutaneous coronary intervention ?: systematic review and meta-analysis</title><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Huang, Taiyuan ; Zhou, Qi ; Yang, Yuan ; Luo, Suxin</creator><creatorcontrib>Huang, Taiyuan ; Zhou, Qi ; Yang, Yuan ; Luo, Suxin</creatorcontrib><description>[...]most relevant studies obtained a preponderance of western population, therefore the presumptive magnitude of cardiac benefit merits scrutiny in Asian population.Our aim is to synthesise data from major randomized controlled trials to gain insight into this controversy.Methods Literature in Medline and Embase database from inception to 31 March 2018 were scrutinized for relevant studies using Internet-based search engines. 1919 patients were identified from 9 randomized studies for the present meta-analysis.The primary endpoint was the 30-day incidence of major adverse cardiac events (MACEs) inclusive of death,myocardial infarction (MI), stroke, target vessel revascularization (TVR).Results High dose statin loading was associated with a significant lower 30-day rate of MACEs compared with conventional care (6.96% vs. 12.3%; odds ratio [OR]: 0.47; 95% confidence interval [CI]: 0.30 to 0.74; p = 0.001), driven by reduction in the occurrence of MI (5% vs. 8.73%; OR: 0.50; 95% CI: 0.34 to 0.73; p = 0.0004) whereas no significant differences in death (0.2% vs. 0.9%; OR: 0.37; 95% CI: 0.09 to 1.44; p = 0.15), stroke (0.5% vs. 0.8%; OR: 0.63; 95% CI: 0.20 to 1.98; p =0.43) or TVR (0.7% vs. 1.6%; OR: 0.54; 95% CI: 0.23 to 1.27; p =0.16). To assess whether specific category of statin was more likely related to the optimal results, a subgroup analysis was performed for studies where rosuvastatin or atorvastatin was prescribed in high dose statin loading, and a prominent benefit was observed in the rosuvastatin subgroup (OR: 0.37; 95% CI: 0.24 to 0.58; p = 0.0001) with absence of heterogeneity (I2 = 0%; p = 0.74), whereas pretreatment with high dose of atorvastatin did not significantly attenuate MACEs rate within 30 days post PCI. Based on the visual inspection of the funnel plot and Egger's test for MACEs, the presence of a small publication bias was suggested.Conclusions From the available RCT data pertaining to high dose statin loading prior to PCI in eastern Asian patients with ACS, a consistent tendency was revealed in favor of MACEs and the component endpoints of death or MI occurrence 30 days post PCI as in some large clinical trials conducted in western population.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2018.08.539</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Angioplasty ; Cardiology ; Clinical trials ; Confidence intervals ; Death ; Dosage ; Inspection ; Meta-analysis ; Myocardial infarction ; Population ; Randomization ; Search engines ; Statins ; Subgroups ; Systematic review</subject><ispartof>Journal of the American College of Cardiology, 2018-10, Vol.72 (16), p.C108-C109</ispartof><rights>2018</rights><rights>Copyright Elsevier Limited Oct 16, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2018.08.539$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids></links><search><creatorcontrib>Huang, Taiyuan</creatorcontrib><creatorcontrib>Zhou, Qi</creatorcontrib><creatorcontrib>Yang, Yuan</creatorcontrib><creatorcontrib>Luo, Suxin</creatorcontrib><title>GW29-e1034 Can eastern Asian population with acute coronary syndrome derive short-term cardiac benefit from high dose statin loading prior to percutaneous coronary intervention ?: systematic review and meta-analysis</title><title>Journal of the American College of Cardiology</title><description>[...]most relevant studies obtained a preponderance of western population, therefore the presumptive magnitude of cardiac benefit merits scrutiny in Asian population.Our aim is to synthesise data from major randomized controlled trials to gain insight into this controversy.Methods Literature in Medline and Embase database from inception to 31 March 2018 were scrutinized for relevant studies using Internet-based search engines. 1919 patients were identified from 9 randomized studies for the present meta-analysis.The primary endpoint was the 30-day incidence of major adverse cardiac events (MACEs) inclusive of death,myocardial infarction (MI), stroke, target vessel revascularization (TVR).Results High dose statin loading was associated with a significant lower 30-day rate of MACEs compared with conventional care (6.96% vs. 12.3%; odds ratio [OR]: 0.47; 95% confidence interval [CI]: 0.30 to 0.74; p = 0.001), driven by reduction in the occurrence of MI (5% vs. 8.73%; OR: 0.50; 95% CI: 0.34 to 0.73; p = 0.0004) whereas no significant differences in death (0.2% vs. 0.9%; OR: 0.37; 95% CI: 0.09 to 1.44; p = 0.15), stroke (0.5% vs. 0.8%; OR: 0.63; 95% CI: 0.20 to 1.98; p =0.43) or TVR (0.7% vs. 1.6%; OR: 0.54; 95% CI: 0.23 to 1.27; p =0.16). To assess whether specific category of statin was more likely related to the optimal results, a subgroup analysis was performed for studies where rosuvastatin or atorvastatin was prescribed in high dose statin loading, and a prominent benefit was observed in the rosuvastatin subgroup (OR: 0.37; 95% CI: 0.24 to 0.58; p = 0.0001) with absence of heterogeneity (I2 = 0%; p = 0.74), whereas pretreatment with high dose of atorvastatin did not significantly attenuate MACEs rate within 30 days post PCI. Based on the visual inspection of the funnel plot and Egger's test for MACEs, the presence of a small publication bias was suggested.Conclusions From the available RCT data pertaining to high dose statin loading prior to PCI in eastern Asian patients with ACS, a consistent tendency was revealed in favor of MACEs and the component endpoints of death or MI occurrence 30 days post PCI as in some large clinical trials conducted in western population.</description><subject>Acute coronary syndromes</subject><subject>Angioplasty</subject><subject>Cardiology</subject><subject>Clinical trials</subject><subject>Confidence intervals</subject><subject>Death</subject><subject>Dosage</subject><subject>Inspection</subject><subject>Meta-analysis</subject><subject>Myocardial infarction</subject><subject>Population</subject><subject>Randomization</subject><subject>Search engines</subject><subject>Statins</subject><subject>Subgroups</subject><subject>Systematic review</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9Uc2q1DAULqLgePUFXB1w3ZqfZpqKIJdBr8IFN4rLkElP76RMk5qkc5kn9XU84wjuXIXA93u-qnrNWcMZ376dmsk61wjGdcN0o2T_pNpwpXQtVd89rTask6rmrO-eVy9ynhhjW837TfXr7ofoa-RMtrCzAdDmginAbfb0W-KyHm3xMcCjLwewbi0ILqYYbDpDPochxRlhwORPCPkQU6mJP4OzafDWwR4Djr7ASDg4-IcDDDETspBqgGO0gw8PsCQfE5QICyaysAHjmv_5-ECaJwx_gnx4R74UciYFBwlPHh_BhgFmLLa2wR7P2eeX1bPRHjO--vveVN8_ffy2-1zff737sru9rx0Xra7FKJneI9NMqxY1WtnSJdReMI1M8nYrxah6Lrc9jkqPve0kF1y13UgM7Pbypnpz1V1S_LliLmaKa6IQ2QjOOy4U2RBKXFEuxZwTjoYaz1TNcGYuA5rJXAY0lwEN04YGJNL7KwkpP7VMJjuPweHgE7pihuj_R_8NuOmnrg</recordid><startdate>20181016</startdate><enddate>20181016</enddate><creator>Huang, Taiyuan</creator><creator>Zhou, Qi</creator><creator>Yang, Yuan</creator><creator>Luo, Suxin</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20181016</creationdate><title>GW29-e1034 Can eastern Asian population with acute coronary syndrome derive short-term cardiac benefit from high dose statin loading prior to percutaneous coronary intervention ?: systematic review and meta-analysis</title><author>Huang, Taiyuan ; Zhou, Qi ; Yang, Yuan ; Luo, Suxin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1248-2f308be080854e8ea340345b208e0314632f591369ef58f9a73121547f808e7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acute coronary syndromes</topic><topic>Angioplasty</topic><topic>Cardiology</topic><topic>Clinical trials</topic><topic>Confidence intervals</topic><topic>Death</topic><topic>Dosage</topic><topic>Inspection</topic><topic>Meta-analysis</topic><topic>Myocardial infarction</topic><topic>Population</topic><topic>Randomization</topic><topic>Search engines</topic><topic>Statins</topic><topic>Subgroups</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Taiyuan</creatorcontrib><creatorcontrib>Zhou, Qi</creatorcontrib><creatorcontrib>Yang, Yuan</creatorcontrib><creatorcontrib>Luo, Suxin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Taiyuan</au><au>Zhou, Qi</au><au>Yang, Yuan</au><au>Luo, Suxin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GW29-e1034 Can eastern Asian population with acute coronary syndrome derive short-term cardiac benefit from high dose statin loading prior to percutaneous coronary intervention ?: systematic review and meta-analysis</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2018-10-16</date><risdate>2018</risdate><volume>72</volume><issue>16</issue><spage>C108</spage><epage>C109</epage><pages>C108-C109</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>[...]most relevant studies obtained a preponderance of western population, therefore the presumptive magnitude of cardiac benefit merits scrutiny in Asian population.Our aim is to synthesise data from major randomized controlled trials to gain insight into this controversy.Methods Literature in Medline and Embase database from inception to 31 March 2018 were scrutinized for relevant studies using Internet-based search engines. 1919 patients were identified from 9 randomized studies for the present meta-analysis.The primary endpoint was the 30-day incidence of major adverse cardiac events (MACEs) inclusive of death,myocardial infarction (MI), stroke, target vessel revascularization (TVR).Results High dose statin loading was associated with a significant lower 30-day rate of MACEs compared with conventional care (6.96% vs. 12.3%; odds ratio [OR]: 0.47; 95% confidence interval [CI]: 0.30 to 0.74; p = 0.001), driven by reduction in the occurrence of MI (5% vs. 8.73%; OR: 0.50; 95% CI: 0.34 to 0.73; p = 0.0004) whereas no significant differences in death (0.2% vs. 0.9%; OR: 0.37; 95% CI: 0.09 to 1.44; p = 0.15), stroke (0.5% vs. 0.8%; OR: 0.63; 95% CI: 0.20 to 1.98; p =0.43) or TVR (0.7% vs. 1.6%; OR: 0.54; 95% CI: 0.23 to 1.27; p =0.16). To assess whether specific category of statin was more likely related to the optimal results, a subgroup analysis was performed for studies where rosuvastatin or atorvastatin was prescribed in high dose statin loading, and a prominent benefit was observed in the rosuvastatin subgroup (OR: 0.37; 95% CI: 0.24 to 0.58; p = 0.0001) with absence of heterogeneity (I2 = 0%; p = 0.74), whereas pretreatment with high dose of atorvastatin did not significantly attenuate MACEs rate within 30 days post PCI. Based on the visual inspection of the funnel plot and Egger's test for MACEs, the presence of a small publication bias was suggested.Conclusions From the available RCT data pertaining to high dose statin loading prior to PCI in eastern Asian patients with ACS, a consistent tendency was revealed in favor of MACEs and the component endpoints of death or MI occurrence 30 days post PCI as in some large clinical trials conducted in western population.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2018.08.539</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-10, Vol.72 (16), p.C108-C109
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_2117125248
source ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Acute coronary syndromes
Angioplasty
Cardiology
Clinical trials
Confidence intervals
Death
Dosage
Inspection
Meta-analysis
Myocardial infarction
Population
Randomization
Search engines
Statins
Subgroups
Systematic review
title GW29-e1034 Can eastern Asian population with acute coronary syndrome derive short-term cardiac benefit from high dose statin loading prior to percutaneous coronary intervention ?: systematic review and meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A15%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GW29-e1034%20Can%20eastern%20Asian%20population%20with%20acute%20coronary%20syndrome%20derive%20short-term%20cardiac%20benefit%20from%20high%20dose%20statin%20loading%20prior%20to%20percutaneous%20coronary%20intervention%20?:%20systematic%20review%20and%20meta-analysis&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Huang,%20Taiyuan&rft.date=2018-10-16&rft.volume=72&rft.issue=16&rft.spage=C108&rft.epage=C109&rft.pages=C108-C109&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2018.08.539&rft_dat=%3Cproquest_cross%3E2117125248%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2117125248&rft_id=info:pmid/&rft_els_id=S0735109718363563&rfr_iscdi=true